Phoenix Pharma Patents – Key Insights and Stats

Phoenix Pharma has a total of 5 patents globally, out of which 4 have been granted. Of these 5 patents, 100% patents are active. Germany is where Phoenix Pharma has filed the all the patents. Parallelly, Germany seems to be the main focused R&D center and is also the origin country of Phoenix Pharma.

Phoenix Pharma was founded in the year 1994 by Adolf Merckle. Company is doing business in pharmaceuticals. As of December 2021, Phoenix Pharma has a market cap of $6.385 Billion.

Do read about some of the most popular patents of Phoenix Pharma which have been covered by us in this article and also you can find Phoenix Pharma’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Phoenix Pharma’s patent portfolio.

How many patents does Phoenix Pharma have?

Phoenix Pharma has a total of 5 patents globally. These patents belong to 5 unique patent families. Out of 5 patents, 5 patents are active.

How many Phoenix Pharma patents are Alive/Dead?

Worldwide Patents

Phoenix Pharma Worldwide Legal Trends

Patent Families

Phoenix Pharma Patent Portfolio

How Many Patents did Phoenix Pharma File Every Year?

Phoenix Pharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPhoenix Pharma Applications FiledPhoenix Pharma Patents Granted
201621
201732
20181

How Many Patents did Phoenix Pharma File in Different Countries?

Phoenix Pharma Patent Portfolio Worldwide Filing

Countries in which Phoenix Pharma Filed Patents

CountryPatents
Germany5

Where are Research Centers of Phoenix Pharma Patents Located?

Phoenix Pharma R&D Centers

What Percentage of Phoenix Pharma US Patent Applications were Granted?

Phoenix Pharma (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 66.67%.

Below are the key stats of Phoenix Pharma patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Phoenix Pharma?

Law FirmTotal ApplicationSuccess Rate
Cr Miles P C1275.00%
Craig R Miles10%
Seyfarth Shaw Llp10.00%

In Europe, the PHOENIX group is a significant healthcare provider. It provides people with pharmaceuticals and medical supplies on a daily basis.

The company’s principal activity is pharmaceutical wholesale, which has a unique geographic reach throughout Europe. It has more than 161 distribution centres in 26 countries that supply pharmaceuticals and healthcare items to pharmacies, doctors, and medical facilities.

It also provides “All-in-One” specialised services and service solutions to over 200 pharmaceutical businesses around Europe. The pharmaceutical industry, wholesalers, pharmacies, and patients are all connected through it. Logistics is one priority, while business intelligence and patient services are another.

List of Phoenix Pharma

Phoenix Pharma PatentsTitle (English)
DE202017006771U1Electronic POS system
DE202017105345U1Apparatus for processing data and an IT system for pharmacies with such a device
DE202017105370U1IT system for pharmacies
DE202016105610U1Data processing system
DE102016119315A1Pharmacies facility

Table of Content

Insights you may find interesting

Related Articles

Fiberstore Patents – Insights & Stats (Updated 2024)

Fiberstore has a total of 326 patents globally, out of which 285 have been granted. Of these 326 patents, more than 97% patents are active. China is where Fiberstore has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.